110 related articles for article (PubMed ID: 2196260)
1. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.
Honeybourne D; Andrews JM; Ashby JP; Lodwick R; Wise R
Thorax; 1988 Sep; 43(9):715-9. PubMed ID: 3194878
[TBL] [Abstract][Full Text] [Related]
3. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy.
Bergogne-Bérézin E; Muller-Serieys C; Aubier M; Dombret MC
Eur J Clin Pharmacol; 1994; 46(1):87-8. PubMed ID: 8005193
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
[TBL] [Abstract][Full Text] [Related]
5. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
Bächer K; Schaeffer M; Lode H; Nord CE; Borner K; Koeppe P
J Antimicrob Chemother; 1992 Sep; 30(3):365-75. PubMed ID: 1452502
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue penetration of cefepime.
Nye KJ; Shi YG; Andrews JM; Wise R
J Antimicrob Chemother; 1989 Jul; 24(1):23-8. PubMed ID: 2777727
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of temafloxacin in serum and bronchial mucosa.
Baldwin DR; Wilkinson L; Andrews JM; Ashby JP; Wise R; Honeybourne D
Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):432-4. PubMed ID: 2387297
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
Baldwin DR; Wise R; Andrews JM; Honeybourne D
J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
[TBL] [Abstract][Full Text] [Related]
9. The penetration of fleroxacin into bronchial mucosa.
Wise R; Honeybourne D; Andrews JM; Ashby JP
J Antimicrob Chemother; 1988 Aug; 22(2):203-6. PubMed ID: 3141344
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of cefodizime in bronchial secretions after single intravenous administration.
Pacheco Y; Pirollet B; Taviot B; Coppere B; Perrin-Fayolle M; Dagrosa EE; Damm D
Arzneimittelforschung; 1993 Aug; 43(8):924-6. PubMed ID: 8216455
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic concentrations of cefepime.
Delcenserie R; Dellion-Lozinguez MP; Yzet T; Lepointe B; Hary L; Badoui R; Verhaeghe P; Andrejak M; Dupas JL
J Antimicrob Chemother; 2001 May; 47(5):711-3. PubMed ID: 11328792
[TBL] [Abstract][Full Text] [Related]
13. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.
Gould IM; Harvey G; Golder D; Reid TM; Watt SJ; Friend JA; Legge JS; Douglas JG
Thorax; 1994 Oct; 49(10):999-1001. PubMed ID: 7974318
[TBL] [Abstract][Full Text] [Related]
14. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
Abd El-Aty AM; Goudah A; Mouneir SM; Sunwoo YE; Jang JH; Shin JG; Shim JH; Shimoda M
Vet Res Commun; 2007 Jan; 31(1):67-75. PubMed ID: 17186405
[TBL] [Abstract][Full Text] [Related]
15. Bronchial penetration of ofloxacin after single and multiple oral dosage.
Davey PG; Precious E; Winter J
J Antimicrob Chemother; 1991 Mar; 27(3):335-41. PubMed ID: 2037539
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
[TBL] [Abstract][Full Text] [Related]
17. Ocular penetration of cefepime following systemic administration in humans.
Ozdamar A; Aras C; Ozturk R; Karacorlu M; Bahcecioglu H; Ozkan S
Ophthalmic Surg Lasers; 2001; 32(1):25-9. PubMed ID: 11195739
[TBL] [Abstract][Full Text] [Related]
18. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
Cook PJ; Andrews JM; Wise R; Honeybourne D
J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
[TBL] [Abstract][Full Text] [Related]
19. The penetration of novel intravenous cephalosporins into the lung.
Baldwin DR
J Chemother; 1996 Feb; 8 Suppl 2():71-82. PubMed ID: 8738849
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of cefepime (BMY-28142), a broad-spectrum cephalosporin, in dogs.
Stampley AR; Brown MP; Gronwall RR; Castro L; Stone HW
Cornell Vet; 1992 Jan; 82(1):69-77. PubMed ID: 1740062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
